| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $1.29 (Miss by $-0.65) |
| EPS GAAP Actual | $1.29 (Miss by $-0.65) |
| Revenue Actual | $1.5449B |
| Revenue Surprise | Beat by $1544.9M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.57512 |
| EPS GAAP Estimate | $2.57512 |
| Revenue Estimate | $1.634549779B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 18.08 | 11.29 | 17.68882 | 18.67911 | 3 |
| Dec 2028 | 16.82975 | 12.13 | 16.02985 | 18.12996 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.3 | -0.96275 | 1.5449B | 6.67% | -44.76M |
| FQ2 2025 (Jun 2025) | 1.54 | -0.896 | 1.537B | 6.93% | -90.61M |
| FQ1 2025 (Mar 2025) | 1.07 | 1.07 | 1.442B | 3.65% | 1442M |
| FQ4 2024 (Dec 2024) | 2.24 | 2.24 | 1.4194B | 6.55% | 1419.4M |
| FQ3 2024 (Sep 2024) | 1.98 | 1.98 | 1.4418B | 8.51% | 1441.8M |
| FQ2 2024 (Jun 2024) | 1.32 | 1.32 | 1.4305B | 7.89% | 1430.5M |
| FQ1 2024 (Mar 2024) | 1.01 | 1.01 | 1.3894B | 6.29% | 1389.4M |
| FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 1.3265B | 100% | 1326.5M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.57512
Consensus Revenue Estimates
1.634549779B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.27 | -- | 3.13029 | 3.40239 | 6 |
| FQ3 2027 (Sep 2027) | 3 | -- | 2.87182 | 3.12146 | 6 |
| FQ2 2027 (Jun 2027) | 2.93 | -- | 2.80481 | 3.04862 | 6 |
| FQ1 2027 (Mar 2027) | 2.5 | -- | 2.39318 | 2.60121 | 6 |
| FQ4 2026 (Oct 2026) | 2.95338 | -- | 2.91448 | 3.02448 | 6 |
| FQ3 2026 (Jul 2026) | 2.53961 | 48.81 | 2.50616 | 2.60075 | 11 |
| FQ2 2026 (Jun 2026) | 2.89501 | 46.81 | 2.83524 | 2.96084 | 9 |
| FQ1 2026 (Mar 2026) | 2.19184 | 51.18 | 2.14659 | 2.24168 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.91B | -- | 1.85B | 1.97B | 6 |
| FQ3 2027 (Sep 2027) | 1.92B | -- | 1.86B | 1.98B | 6 |
| FQ2 2027 (Jun 2027) | 1.9B | -- | 1.84B | 1.96B | 6 |
| FQ1 2027 (Mar 2027) | 1.84B | -- | 1.78B | 1.89B | 6 |
| FQ4 2026 (Oct 2026) | 1.76B | -- | 1.74B | 1.79B | 6 |
| FQ3 2026 (Jul 2026) | 1.72B | 10.43 | 1.71B | 1.76B | 6 |
| FQ2 2026 (Jun 2026) | 1.76B | 12.58 | 1.73B | 1.79B | 12 |
| FQ1 2026 (Mar 2026) | 1.69B | 14.51 | 1.66B | 1.72B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.26275 | 1.3 | -0.96275 | -74.06% |
| FQ2 2025 (Jun 2025) | 2.436 | 1.54 | -0.896 | -58.18% |
| FQ1 2025 (Mar 2025) | 1.07 | 1.07 | 100% | |
| FQ4 2024 (Dec 2024) | 2.24 | 2.24 | 100% | |
| FQ3 2024 (Sep 2024) | 1.98 | 1.98 | 100% | |
| FQ2 2024 (Jun 2024) | 1.32 | 1.32 | 100% | |
| FQ1 2024 (Mar 2024) | 1.01 | 1.01 | 100% | |
| FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.59B | $1.54B | $-44.76M | -2.9% |
| FQ2 2025 (Jun 2025) | $1.63B | $1.54B | $-90.61M | -5.9% |
| FQ1 2025 (Mar 2025) | $0B | $1.44B | $1442M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.42B | $1419.4M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.44B | $1441.8M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.43B | $1430.5M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.39B | $1389.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.33B | $1326.5M | 100% |